Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Gilead's reliance on CMOs gives firm 'flexibility' says CFO

Reliance on CMOs and CROs has allowed the flexibility to make Gilead a top 10 pharma firm, and the use of third-parties will remain part of its strategy according to the CFO.

News in brief

Amarantus selects Chiltern for Phase IIb study

Neurologically-focused biotech Amarantus BioScience has entered into a clinical trial agreement with CRO Chiltern to manage the clinical research and monitoring program services for the Phase IIb study of eltoprazine in Parkinson’s disease levodopa-induced dyskinesia (PD-LID).

inVentiv expands NIS services to help stem confusion on new EU trials regulation

inVentiv Health has expanded its compliance products and services to assist biopharma companies conducting non-interventional studies (NIS). 

House introduces companion bill to offer CROs a share of R&D tax credit

In a House bill that largely mirrors one reintroduced earlier this year in the Senate, CROs (contract research organizations) would be able to capture a share of the R&D tax credit, thereby making the US more competitive with other countries that offer such credits.

FDA offers ‘encouraging’ draft guidance for adaptive device trials, expert says

Adaptive clinical trial designs can be used in medical device studies as long as they are for “prospectively planned modifications based on accumulating study data without undermining the trial’s integrity and validity,” the FDA says.

On the move: arrivals and departures at Parexel, Novartis, Roche

Our round-up of the latest hires and deals in outsourcing.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...